NMPA Approval

Mirabegron Sustained-release Tablets

Approval Number

国药准字H20253163

Company乐泰药业有限公司

Registration Date

January 14, 2025

Drug Information

Generic Name

米拉贝隆缓释片

Dosage Form

片剂

Strength

50mg

Drug Type

化学药品

Registration Date

January 14, 2025

Company Information

Applicant Company

Company Name乐泰药业有限公司

Company Address

黑龙江省哈尔滨市呼兰区利民开发区珠海路

Manufacturing Company

Company Name乐泰药业有限公司

Company Address

哈尔滨市利民经济技术开发区北京路

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

米拉贝隆缓释片 - NMPA 批准文号 | MedPath